Sona Nanotech Inc. announced the filing of a U.S. provisional patent application regarding a gold nanorod conjugation concept for targeted drug delivery and deployment applications in the medical field. The Company intends to convert the filing to an international patent application and/or regular patent applications in various countries, including the U.S., over the next year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 CAD | -5.66% |
|
-12.28% | +4.17% |
21/05 | Sona Nanotech Appoints Chief Medical Officer, Files Provisional Conjugation Patent | MT |
21/05 | Sona Nanotech Inc. Appoints Dr. Carman Giacomantonio Md, Msc., Frcsc as Chief Medical Officer | CI |
1st Jan change | Capi. | |
---|---|---|
+4.17% | 18.03M | |
-5.81% | 180B | |
-1.63% | 106B | |
-4.14% | 67.55B | |
-6.56% | 46.11B | |
+13.22% | 45.79B | |
+6.13% | 41.61B | |
+19.93% | 31.07B | |
+13.61% | 24.77B | |
-5.36% | 24.27B |
- Stock Market
- Equities
- SONA Stock
- News Sona Nanotech Inc.
- Sona Nanotech Inc. Files Provisional Conjugation Patent